| Kazda C, Gallwitz B, Simó R, et al.
The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics. [JOURNAL ARTICLE]
Diabetes Obes Metab 2009 Sep 13.
Abstract | Full Citation | Find Related Articles |
| Croom KF, McCormack PL
Liraglutide: a review of its use in type 2 diabetes mellitus. [Journal Article]
Drugs 2009; 69(14):1985-2004.
Abstract | Full Citation | Find Related Articles |
| John Betteridge D
CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone. [JOURNAL ARTICLE]
Fundam Clin Pharmacol 2009 Sep 10.
Abstract | Full Citation |
| Cooperberg BA, Cryer PE
Beta-Cell-Mediated Signaling Predominates Over Direct Alpha-Cell Signaling in the Regulation of Glucagon Secretion in Humans. [JOURNAL ARTICLE]
Diabetes Care 2009 Sep 3.
Abstract | Full Citation |
| Mori A, Lee P, Yamashita T, et al.
Effect of glimepiride and nateglinide on serum insulin and glucose concentration in healthy cats. [JOURNAL ARTICLE]
Vet Res Commun 2009 Sep 2.
Abstract | Full Citation |
| Müller G, Jung C, Wied S, et al.
Induced translocation of glycosylphosphatidylinositol-anchored proteins from lipid droplets to adiposomes in rat adipocytes. [JOURNAL ARTICLE]
Br J Pharmacol 2009 Aug 24.
Abstract | Full Citation |
| Ebato C, Shimizu T, Arakawa M, et al.
Effect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): Comparison of twice-daily biphasic insulin aspart 30 with or without glimepiride in type 2 diabetic patients poorly controlled with sub-maximal glimepiride. [JOURNAL ARTICLE]
Diabetes Res Clin Pract 2009 Aug 17.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Russell-Jones D, Vaag A, Schmitz O, et al.
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. [JOURNAL ARTICLE]
Diabetologia 2009 Aug 14.
Abstract | Full Citation |
| Polonsky T, Mazzone T, Davidson M
The clinical implications of the CHICAGO study for the management of cardiovascular risk in patients with type 2 diabetes mellitus. [Journal Article, Research Support, Non-U.S. Gov't]
Trends Cardiovasc Med 2009 Apr; 19(3):94-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Neumiller JJ, Campbell RK
Liraglutide: A Once-Daily Incretin Mimetic for the Treatment of Type 2 Diabetes Mellitus (September)(CE). [JOURNAL ARTICLE]
Ann Pharmacother 2009 Jul 28.
Abstract | Full Citation | Find Related Articles |
   |
